These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24491811)

  • 41. Pulmonary arterial hypertension and sepsis: prothrombotic profile and inflammation can changes pulmonary mechanics?
    Tauil KM; Gaio E; Melo-Silva CA; Carvalho RS; Amado VM
    Med Hypotheses; 2014 Sep; 83(3):290-1. PubMed ID: 24957506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imatinib mesylate for the treatment of pulmonary arterial hypertension.
    ten Freyhaus H; Dumitrescu D; Berghausen E; Vantler M; Caglayan E; Rosenkranz S
    Expert Opin Investig Drugs; 2012 Jan; 21(1):119-34. PubMed ID: 22074410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
    Huh JW; Kim SY; Lee JH; Lee YS
    Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelial progenitor cells and pulmonary arterial hypertension.
    Chen H; Strappe P; Chen S; Wang LX
    Heart Lung Circ; 2014 Jul; 23(7):595-601. PubMed ID: 24680485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lessons from oncology to understand and treat pulmonary hypertension.
    Adnot S; Eddahibi S
    Int J Clin Pract Suppl; 2007 Dec; (158):19-25. PubMed ID: 18078390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin.
    Van Hung T; Emoto N; Vignon-Zellweger N; Nakayama K; Yagi K; Suzuki Y; Hirata K
    Life Sci; 2014 Nov; 118(2):313-28. PubMed ID: 24412382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Guo L; Li M; Chen Y; Wang Q; Tian Z; Pan S; Zeng X; Ye S
    Arthritis Rheumatol; 2015 Sep; 67(9):2394-402. PubMed ID: 26018988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pulmonary arterial hypertension and microRNAs--an ever-growing partnership.
    Wang Y; Xue XY; Liu YX; Wang KF; Zang XF; Wang J; Wang PL; Zhang J; Pan L; Zhang SY; Wang JX
    Arch Med Res; 2013 Oct; 44(7):483-7. PubMed ID: 24051036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenic mechanisms of pulmonary arterial hypertension.
    Chan SY; Loscalzo J
    J Mol Cell Cardiol; 2008 Jan; 44(1):14-30. PubMed ID: 17950310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.
    Diller GP; van Eijl S; Okonko DO; Howard LS; Ali O; Thum T; Wort SJ; Bédard E; Gibbs JS; Bauersachs J; Hobbs AJ; Wilkins MR; Gatzoulis MA; Wharton J
    Circulation; 2008 Jun; 117(23):3020-30. PubMed ID: 18519847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rho-kinase inhibitors.
    Fukumoto Y; Shimokawa H
    Handb Exp Pharmacol; 2013; 218():351-63. PubMed ID: 24092347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension.
    Moudgil R; Michelakis ED; Archer SL
    Microcirculation; 2006 Dec; 13(8):615-32. PubMed ID: 17085423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelial and Smooth Muscle Cell Interactions in the Pathobiology of Pulmonary Hypertension.
    Gao Y; Chen T; Raj JU
    Am J Respir Cell Mol Biol; 2016 Apr; 54(4):451-60. PubMed ID: 26744837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathobiology of pulmonary hypertension. The role of platelets and thrombosis.
    Herve P; Humbert M; Sitbon O; Parent F; Nunes H; Legal C; Garcia G; Simonneau G
    Clin Chest Med; 2001 Sep; 22(3):451-8. PubMed ID: 11590840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Physiopathology of pulmonary arterial hypertension. Cellular and molecular aspects].
    Perros F; Humbert M
    Presse Med; 2005 Feb; 34(3):232-42. PubMed ID: 15798538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
    Schermuly RT; Pullamsetti SS; Kwapiszewska G; Dumitrascu R; Tian X; Weissmann N; Ghofrani HA; Kaulen C; Dunkern T; Schudt C; Voswinckel R; Zhou J; Samidurai A; Klepetko W; Paddenberg R; Kummer W; Seeger W; Grimminger F
    Circulation; 2007 May; 115(17):2331-9. PubMed ID: 17438150
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.
    Perros F; Montani D; Dorfmüller P; Durand-Gasselin I; Tcherakian C; Le Pavec J; Mazmanian M; Fadel E; Mussot S; Mercier O; Hervé P; Emilie D; Eddahibi S; Simonneau G; Souza R; Humbert M
    Am J Respir Crit Care Med; 2008 Jul; 178(1):81-8. PubMed ID: 18420966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension.
    Santos-Gomes J; Le Ribeuz H; Brás-Silva C; Antigny F; Adão R
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular senescence in the pathogenesis of pulmonary arterial hypertension: the good, the bad and the uncertain.
    Safaie Qamsari E; Stewart DJ
    Front Immunol; 2024; 15():1403669. PubMed ID: 39156894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary arterial hypertension and the potential roles of metallothioneins: A focused review.
    Maarman GJ
    Life Sci; 2018 Dec; 214():77-83. PubMed ID: 30355531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.